Wells Fargo & Company MN Has $236.32 Million Stock Position in Burlington Stores, Inc. Intrust Bank NA Increases Stock Holdings in Booz Allen Hamilton Holding Co. Wells Fargo & Company MN Grows Position in Vanguard Mid-Cap Growth ETF, Wells Fargo & Company MN Grows Position in Vanguard Health Care Index Fund ETF Shares. S&P 500 0.00%. Read our. Available for free with registration. Acasti Pharma Inc. (NASDAQ:ACST) was the target of a large growth in short interest during the month of September. A rank of 34 means that 66% of stocks appear more favorable to our system. Seeking Alpha - 3 months ago Acasti Pharma Inc. (ACST) CEO Jan D'Alvise on Q4 2020 Results - Earnings Call Transcript ACST stock was already a tough gamble due to the competition for omega-3-based drugs. Reports 30.5% and 36.7% reduction in triglyceride levels, compared with baseline, among patients receiving CaPre at 12 and 26 weeks respectively, as well as 42.2% reduction in triglyceride lev... Micro-cap biopharma Acasti Pharma Inc (NASDAQ: ACST) issued an update regarding a delay in a clinical readout. Virtu Financial LLC owned about 0.28% of Acasti … "remove":"add"](select.closed),dom.control.setAttribute("aria-expanded",o)}function onToggleClicked(){var l=!isPanelOpen();setPanelState(l)}function onWindowScroll(){window.requestAnimationFrame(function() {var l=isPanelOpen(),n=0===(document.body.scrollTop||document.documentElement.scrollTop);n||l||!allowExpand?n&&l&&(allowExpand=!0,setPanelState(!1)):(allowExpand=!1,setPanelState(!0))});}pencilInit(".js-sub-pencil",!1); // via darwin-bg var slideIndex = 0; carousel(); function carousel() { var i; var x = document.getElementsByClassName("subs_valueprop"); for (i = 0; i < x.length; i++) { x[i].style.display = "none"; } slideIndex++; if (slideIndex> x.length) { slideIndex = 1; } x[slideIndex - 1].style.display = "block"; setTimeout(carousel, 2500); } //, Unchecking box will stop auto data updates, Tuesday’s analyst upgrades and downgrades, Market movers: Stocks that saw action on Monday - and why, Market movers: Stocks that saw action on Tuesday and why. 351 King Street East, Suite 1600, Toronto, ON Canada, M5A 0N1, Just $1.99 per week for the first 24 weeks, var select={root:".js-sub-pencil",control:".js-sub-pencil-control",open:"o-sub-pencil--open",closed:"o-sub-pencil--closed"},dom={},allowExpand=!0;function pencilInit(o){var e=arguments.length>1&&void 0!==arguments[1]&&arguments[1];select.root=o,dom.root=document.querySelector(select.root),dom.root&&(dom.control=document.querySelector(select.control),dom.control.addEventListener("click",onToggleClicked),setPanelState(e),window.addEventListener("scroll",onWindowScroll),dom.root.removeAttribute("hidden"))}function isPanelOpen(){return dom.root.classList.contains(select.open)}function setPanelState(o){dom.root.classList[o?"add":"remove"](select.open),dom.root.classList[o? A premium report that provides detailed quantitative assessments of earnings, fundamentals, relative valuation, risk, price momentum and more. But even this major setback isn't the only headwind impacting shares. Acasti Pharma, Inc. (ACST) CEO Jan D'Alvise on Q4 2019 Results - Earnings Call Transcript. Finally, Echelon Wealth Partners restated a “buy” rating and set a $1.40 target price on shares of Acasti Pharma in a research note on Tuesday, June 30th. Shares of Amarin Corp. PLC AMRN, +4.80% rose 4.8% in active afternoon trading Monday, after makers of drugs that rival Amarin's Vascepa, which is used to lower the risk of cardiovascular event... Shares of Acasti Pharma Inc (NASDAQ: ACST), which closed at $2.18 Friday, have entered penny stock territory after a negative data readout. TRILOGY 2 results in February mark the company's last chance. A hedge fund recently bought a new stake in Acasti Pharma stock. Acasti Pharma Announces the Election of Its Directors, Advisory Resolution Approving Compensation, Amendments to Its Stock Option and Equity Incentive Plans, Adoption of Amended & Restated General By-Law and Other Related Matters Approved at Its AGM October 1, 2020 Acasti Announces Review Process of Strategic Alternatives September 29, 2020 Oppenheimer cut shares of Acasti Pharma from an “outperform” rating to a “market perform” rating in a research note on Monday, August 31st. Virtu Financial LLC owned about 0.28% of Acasti Pharma as of its most recent SEC filing. Acasti Pharma stock plunged after disappointing TRILOGY 1 trial results. Since then, ACST shares have decreased by 50.8% and is now trading at $0.1895. All market data (will open in new tab) is provided by Barchart Solutions. Cancel. LAVAL, Québec, Nov. 18, 2019 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti or the “Company”) (NASDAQ: ACST – TSX-V: ACST), a biopharmaceutical innovator focused on the research, developmen... Acasti Pharma Inc. (ACST) CEO Jan D'Alvise on Q2 2020 Results - Earnings Call Transcript, Agreement provides Acasti long-term supply of raw krill oil through commercialization Agreement provides Acasti long-term supply of raw krill oil through commercialization. Trending now. How does the Beige Book influence monetary policy? To view this site properly, enable cookies in your browser. View which stocks have been most impacted by … Log In. View this premium StockCalc report to see this stock's valuation and how it was calculated using fundamental analysis. The post The Future Doesn’t Look Too Bright For Acasti Pharma Stock appea... Acasti hopes a second study of its CaPre drug, due for release next month, shows better results, but most investors have left ACST stock. The fund bought 252,405 shares of the biopharmaceutical company’s stock, valued at approximately $118,000. Acasti Pharma Inc. (ACST) CEO Jan D'Alvise on Q4 2020 Results - Earnings Call Transcript, Identifies “Triglyceride Normalization” phenomenon prior to patient randomization and treatment  as likely contributor to unusually high placebo effect in TRILOGY 1, Plans to report summary of Trilogy 1 data on June 29, 2020 conference call Plans to report summary of Trilogy 1 data on June 29, 2020 conference call, FDA response expected on or before June 30, 2020, Expands existing claims to include any omega-3 phospholipid containing at least 50% phospholipids Expands existing claims to include any omega-3 phospholipid containing at least 50% phospholipids. One of the primary causes of con... Investigation underway into unexpected and inconsistent findings that may have negatively impacted results reported in TRILOGY 1. Acasti Pharma Announces the Election of Its Directors, Advisory Resolution Approving Compensation, Amendments to Its Stock Option and Equity Incentive Plans, Adoption of … Intrust Bank NA Purchases Shares of 6,863 Newmont Co. Air France-KLM SA Receives Average Recommendation of “Sell” from Analysts. The company has a debt-to-equity ratio of 0.01, a quick ratio of 2.34 and a current ratio of 2.34. Acasti Pharma's stock was trading at $0.3849 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Copyright © 2020. The stock has a market cap of $19.65 million, a price-to-earnings ratio of -0.63 and a beta of 1.89. Acasti Pharma stock plunged after the company reported negative trial results. Based on an average trading volume of 5,870,000 shares, the days-to-cover ratio is presently 0.2 days. Aegis cut shares of Acasti Pharma from a “buy” rating to a “hold” rating in a research note on Wednesday, September 2nd. Real-time trade and investing ideas on Acasti Pharma Inc. ACST from the largest community of traders and investors. Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research – including Buy/Hold Recommendations, Earnings Surprises, Estimates and Recommendations History. Mr. Ford assumes the responsibilities formerly held by Jean-Francois Boily, Vice-President, Finance, who recently resigned. However, without FDA approval, the underlying pharmaceutical is merely a gamble. If they plan on doubling-down on CaPre, they need more capital. Several brokerages have recently weighed in on ACST. The lucrative addressable market for therapeutics to treat hypertriglyceridemia is expected to increase in future years due to an unhealthy diet, sedentary lifestyles, and prevalence of obesity. Acasti Pharma Inc. ("Acasti" or the "Company") (NASDAQ: ACST - TSX-V: ACST) announced that it has appointed seasoned financial executive Brian D. Ford as its Chief Financial Officer, effective September 14, 2020. As a follow up to my piece from June 25, 2019, “Home-run Hitters, At Bat With Acasti Pharma”, price target increase from $8.33/share to $11.06/share. Price movement based on the high, low and last over the given period. Acasti Pharma is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. Takes you to an interactive chart which cannot interact. B. Riley dropped their price target on shares of Acasti Pharma from $2.00 to $0.50 and set a “neutral” rating on the stock in a research note on Tuesday, September 1st. DOW 0.00%. A stock valuation and forecasting report include rating, fair value assessment, return forecasts, market ratio-based valuations and comparable analysis. The company's road ahead is filled with risks. What this means: InvestorsObserver gives Acasti Pharma (ACST) an overall rank of 34, which is below average. The firm’s fifty day moving average is $0.22 and its 200 day moving average is $0.54. Rooms Rankings Earnings Calendar Shop. On average, equities research analysts predict that Acasti Pharma will post -0.2 earnings per share for the current year. Pre-Market Earnings Guidance, Affimed (NASDAQ:AFMD) Short Interest Update, Air France-KLM SA (OTCMKTS:AFLYY) Receives Average Recommendation of “Sell” from Analysts, Intrust Bank NA Increases Stock Holdings in Booz Allen Hamilton Holding Co. (NYSE:BAH), Intrust Bank NA Purchases Shares of 6,863 Newmont Co. (NYSE:NEM), Wells Fargo & Company MN Grows Position in Vanguard Mid-Cap Growth ETF (NYSEARCA:VOT), Wells Fargo & Company MN Has $220.21 Million Stock Holdings in DocuSign, Inc. (NASDAQ:DOCU), Wells Fargo & Company MN Has $236.32 Million Stock Position in Burlington Stores, Inc. (NYSE:BURL), Wells Fargo & Company MN Grows Position in Vanguard Health Care Index Fund ETF Shares (NYSEARCA:VHT), Wells Fargo & Company MN Boosts Stock Position in Bright Horizons Family Solutions Inc. (NYSE:BFAM), Wells Fargo & Company MN Increases Stock Holdings in Teledyne Technologies Incorporated (NYSE:TDY), Wells Fargo & Company MN Boosts Position in Manulife Financial Co. (NYSE:MFC), IHS Markit Ltd. (NYSE:INFO) Position Lowered by Wells Fargo & Company MN, Biogen Inc. (NASDAQ:BIIB) Shares Acquired by Wells Fargo & Company MN, WNS (Holdings) Limited (NYSE:WNS) Receives $68.50 Consensus PT from Analysts, Benefitfocus, Inc. (NASDAQ:BNFT) Receives Consensus Recommendation of “Hold” from Brokerages, Wells Fargo & Company MN Acquires 200,251 Shares of Black Knight, Inc. (NYSE:BKI), Wells Fargo & Company MN Acquires 32,924 Shares of Monolithic Power Systems, Inc. (NASDAQ:MPWR), Contrasting Diginex (EQOS) and The Competition, Shopify Inc. (NYSE:SHOP) Position Lessened by Wells Fargo & Company MN, Analysts Set Cameco Co. (NYSE:CCJ) Price Target at $15.30.

Lawn Mower Parts Near Me, Black Friday 2020 Canada Date, Isacord Thread Sets, Mamou Bgc Number, How To Grow Courgettes Vertically, How To Reset Samsung Smart Tv Without Remote, Lamy Fountain Pen Price, Leyton Orient V Tottenham, Christmas Light Installation Company Near Me, Miller Grove High School Notable Alumni, Hindu Baby Girl Names Starting With J With Meaning, Black Friday 2020 Canada Date, Business World Readership, Roberson Middle School, Time And Chance Happen To Them All Sermon, University Of York Postgraduate Acceptance Rate, Blend In Quotes, Ft How To Spend It Slow Travel, Jacob Collier In Too Deep Chords, Maria Brown Attorney, My Dear Melancholy Meaning, Planet Fitness Open, Lipton Black Tea Bags, Tugboat Captain Uk, Shetland Pony For Sale Massachusetts, Antwain Easterling Football, Large Dog Bed Price, Hatha Yoga Sequence 30 Minutes,